Future Therapeutics in Alzheimer's Disease: Development Status of BACE Inhibitors.
- Published in:
- BioDrugs, 2016, v. 30, n. 3, p. 173, doi. 10.1007/s40259-016-0168-3
- By:
- Publication type:
- Article
Works matching IS 11738804 AND DT 2016 AND VI 30 AND IP 3
Results: 8
1
2
Identification of Low-Level Product-Related Variants in Filgrastim Products Presently Available in Highly Regulated Markets.
- Published in:
- BioDrugs, 2016, v. 30, n. 3, p. 233, doi. 10.1007/s40259-016-0169-2
- By:
- Publication type:
- Article
3
Anagrelide and Mutational Status in Essential Thrombocythemia.
- Published in:
- BioDrugs, 2016, v. 30, n. 3, p. 219, doi. 10.1007/s40259-016-0170-9
- By:
- Publication type:
- Article
4
Comparability of Antibody-Mediated Cell Killing Activity Between a Proposed Biosimilar RTXM83 and the Originator Rituximab.
- Published in:
- BioDrugs, 2016, v. 30, n. 3, p. 225, doi. 10.1007/s40259-016-0171-8
- By:
- Publication type:
- Article
5
Adalimumab for Moderately to Severely Active Ulcerative Colitis: A Systematic Review and Meta-Analysis.
- Published in:
- BioDrugs, 2016, v. 30, n. 3, p. 207, doi. 10.1007/s40259-016-0173-6
- By:
- Publication type:
- Article
6
Assessing the Immunogenicity of Biopharmaceuticals.
- Published in:
- BioDrugs, 2016, v. 30, n. 3, p. 195, doi. 10.1007/s40259-016-0174-5
- By:
- Publication type:
- Article
7
Shingles (Herpes Zoster) Vaccine (Zostavax): A Review in the Prevention of Herpes Zoster and Postherpetic Neuralgia.
- Published in:
- BioDrugs, 2016, v. 30, n. 3, p. 243, doi. 10.1007/s40259-016-0180-7
- By:
- Publication type:
- Article
8
Update on Metastatic Uveal Melanoma: Progress and Challenges.
- Published in:
- BioDrugs, 2016, v. 30, n. 3, p. 161, doi. 10.1007/s40259-016-0167-4
- By:
- Publication type:
- Article